Migraines » Blog Archive » NuPathe Reports Positive Phase I Results For NP101, A Novel Transdermal Patch For Acute Migraine

Categories

Add to Technorati Favorites

Recent Posts

Telcagepant Proven As A Safe And Effective Migraine Treatment In Phase III Trial
Patent Foramen Ovale Closure Extremely Promising For Stroke Prevention And Treatment Of Migraine
Overuse Of Narcotics And Barbiturates May Make Migraine Worse
1 In 4 Gulf War Veterans Suffer From Illness Caused By Toxic Exposure
500-Patient Study Measuring Cognitive Processing Efficiency During Migraine Attacks
Breakthrough’s Comment On Research Suggesting Women Who Have Migraines Have A Reduced Risk Of Breast Cancer
Pycnogenol Cut Jetlag Symptoms In Half For Passengers Taking 7- To 9-hour Flights
Women Who Have Migraines Have Lower Breast Cancer Risk
Doctors Stress Pressing Need For Research Into The Best Treatment For Medication Overuse Headaches
Minster Pharmaceuticals Plc Announces Positive Results From Phase II Trial Of Migraine With Aura

Blogroll

Medical Links

Aches And Pains

NuPathe Reports Positive Phase I Results For NP101, A Novel Transdermal Patch For Acute Migraine

July 3rd, 2008 by admin

NuPathe Inc., a privately held specialty pharmaceutical company developing innovative products for the treatment of neurological and psychiatric diseases, announced positive Phase I results for NP101, a novel drug-device patch for acute migraine in clinical development.

More: continued here

Posted in Uncategorized |

Leave a Comment